×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| APOLLO HOSPITALS ENTERPRISE LT | 22004.0 | 3069.0 | 21679.0 | 21.35 | 1,11,815 | 71.1 |
| Max Healthcare Institute Limit | 7738.7 | 1660.3 | 6940.2 | 1.7 | 111767 | 93.2 |
| Mankind Pharma Limited | 26055.8 | 4127.6 | 25413.6 | 9.99 | 106467 | 56.3 |
Apollo Hospitals Enterprises Ltd.,, with Security Code 508869, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,640.8 | 1,688.4 | 1,866.5 | 1,824.3 | 1,894.6 | 1,936.6 | 2,135.4 | 2,054.8 | 2,075.3 | 2,167.9 |
| Expenses | 1,217.6 | 1,270.7 | 1,387.4 | 1,374.0 | 1,444.2 | 1,465.8 | 1,595.1 | 1,543.0 | 1,554.0 | 1,621.8 |
| Operating Profit | 423.2 | 417.7 | 479.1 | 450.3 | 450.4 | 470.8 | 540.3 | 511.8 | 521.3 | 546.1 |
| OPM % | 25.79% | 24.74% | 25.67% | 24.68% | 23.77% | 24.31% | 25.3% | 24.91% | 25.12% | 25.19% |
| Other Income | 42.8 | 17.8 | 64.6 | 51.6 | 46.0 | 27.3 | 120.9 | 107.9 | 91.6 | 32.5 |
| Interest | 60.6 | 60.9 | 59.6 | 60.6 | 68.7 | 63.5 | 65.4 | 62.0 | 63.1 | 58.8 |
| Depreciation | 96.7 | 93.1 | 93.4 | 97.2 | 115.3 | 102.9 | 108.3 | 108.4 | 129.8 | 123.2 |
| Profit before tax | 308.7 | 281.5 | 390.7 | 344.1 | 312.4 | 331.7 | 487.5 | 449.3 | 420.0 | 396.6 |
| Tax % | -26.5% | -23.9% | -24.5% | -23.6% | -23.6% | -24.1% | -24.2% | -24% | -20.6% | 22.6% |
| Net Profit | 226.9 | 214.1 | 294.8 | 262.9 | 238.8 | 251.7 | 369.6 | 341.6 | 333.4 | 306.9 |
| EPS in Rs | 15.78 | 14.89 | 20.5 | 18.28 | 16.61 | 17.51 | 25.71 | 23.76 | 0 | 21.35 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,263.6 | 4,302.2 | 4,417.8 | 4,846.9 | 4,850.6 | 4,943.9 | 5,085.6 | 5,589.3 | 5,526.9 | 5,592.2 |
| Expenses | 3,779.8 | 3,814.1 | 3,908.8 | 4,219.4 | 4,236.9 | 4,303.4 | 4,410.5 | 4,773.8 | 4,765.4 | 4,822.5 |
| Operating Profit | 483.8 | 488.2 | 509.0 | 627.5 | 613.7 | 640.5 | 675.1 | 815.5 | 761.5 | 769.7 |
| OPM % | 11.35% | 11.35% | 11.52% | 12.95% | 12.65% | 12.96% | 13.27% | 14.59% | 13.78% | 13.76% |
| Other Income | 35.4 | 16.4 | 28.2 | 24.1 | 27.8 | 28.1 | 37.2 | 38.2 | 63.8 | 61.1 |
| Interest | 100.0 | 95.4 | 106.2 | 111.3 | 112.6 | 119.3 | 116.4 | 117.5 | 109.8 | 114.8 |
| Depreciation | 153.4 | 159.1 | 166.9 | 163.4 | 167.0 | 189.7 | 177.4 | 184.5 | 184.6 | 211.0 |
| Profit before tax | 265.8 | 250.0 | 264.1 | 375.0 | 361.9 | 359.6 | 418.5 | 551.7 | 530.9 | 505.0 |
| Tax % | -36% | -43.2% | -36.6% | -34.5% | -30.1% | -30.5% | -27.4% | -29.3% | -29.5% | -20% |
| Net Profit | 162.3 | 145.6 | 173.4 | 248.8 | 254.4 | 258.4 | 315.5 | 395.7 | 379.4 | 414.5 |
| EPS in Rs | 10.67 | 10.05 | 11.59 | 16.2 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -3% |
| 3 Years: | 16% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 26% |
| 3 Years: | 108% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 40% |
| 3 Years: | 24% |
| 1 Year: | 16% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 22% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 34% |
| 3 Years: | 109% |
| TTM: | 66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 40% |
| 3 Years: | 24% |
| 1 Year: | 16% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|